Study finds COVID-19 vaccine may reduce virus transmission

FILE – In this Jan. 11, 2021 file photo Mary Williams, right, receives an injection of the Oxford/AstraZeneca vaccine at the mass vaccination centre in Newcastle Upon Tyne, England. The European Medicines Agency is expected on Friday Jan. 29, 2021 to authorize use of the vaccine AstraZeneca developed with Oxford University. It would be the third cleared for use in the EU, after the BioNTech-Pfizer and Moderna vaccines.